Data Scientist Explains How AI's Seductive Power Can Mislead Biomarker Researchers

Today, I am writing about where the rubber squarely meets the road in AI and drug development: the use of algorithms to mine big data for informative patterns. In particular, I share what I believe is an extremely important, fairly critical, ultimately constructive perspective on the challenge of developing valid diagnostic biomarkers, presented by one of the most thoughtful data scientists I know, Imran Haque. 

The full Forbes article can be viewed at this link.